281 related articles for article (PubMed ID: 11561938)
1. Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal.
Silvestri R; Pace-Schott EF; Gersh T; Stickgold R; Salzman C; Hobson JA
J Clin Psychiatry; 2001 Aug; 62(8):642-52. PubMed ID: 11561938
[TBL] [Abstract][Full Text] [Related]
2. SSRI treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects.
Pace-Schott EF; Gersh T; Silvestri R; Stickgold R; Salzman C; Hobson JA
J Sleep Res; 2001 Jun; 10(2):129-42. PubMed ID: 11422727
[TBL] [Abstract][Full Text] [Related]
3. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.
Sharpley AL; Williamson DJ; Attenburrow ME; Pearson G; Sargent P; Cowen PJ
Psychopharmacology (Berl); 1996 Jul; 126(1):50-4. PubMed ID: 8853216
[TBL] [Abstract][Full Text] [Related]
4. [Severe withdrawal symptoms with fever upon stopping paroxetine].
Bakker A
Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1795; author reply 1795-6. PubMed ID: 10494333
[No Abstract] [Full Text] [Related]
5. Contrasting actions of acute or chronic paroxetine and fluvoxamine on morphine withdrawal-induced place conditioning.
Rafieian-Kopaei M; Gray AM; Spencer PS; Sewell RD
Eur J Pharmacol; 1995 Mar; 275(2):185-9. PubMed ID: 7796854
[TBL] [Abstract][Full Text] [Related]
6. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B
J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692
[TBL] [Abstract][Full Text] [Related]
7. Sleep changes during long-term treatment of depression with fluvoxamine--a home-based study.
Wilson SJ; Bell C; Coupland NJ; Nutt DJ
Psychopharmacology (Berl); 2000 May; 149(4):360-5. PubMed ID: 10867963
[TBL] [Abstract][Full Text] [Related]
8. The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine.
Azuma J; Hasunuma T; Kubo M; Miyatake M; Koue T; Higashi K; Fujiwara T; Kitahara S; Katano T; Hara S
Eur J Clin Pharmacol; 2012 Jan; 68(1):29-37. PubMed ID: 21739267
[TBL] [Abstract][Full Text] [Related]
9. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine.
Gervasoni D; Panconi E; Henninot V; Boissard R; Barbagli B; Fort P; Luppi PH
Pharmacol Biochem Behav; 2002 Oct; 73(3):557-63. PubMed ID: 12151030
[TBL] [Abstract][Full Text] [Related]
11. Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram.
Wilson SJ; Bailey JE; Rich AS; Adrover M; Potokar J; Nutt DJ
Eur Neuropsychopharmacol; 2004 Oct; 14(5):367-72. PubMed ID: 15336297
[TBL] [Abstract][Full Text] [Related]
12. Conventional and spectral power analysis of all-night sleep EEG after subchronic treatment with paroxetine in healthy male volunteers.
Schlösser R; Röschke J; Rossbach W; Benkert O
Eur Neuropsychopharmacol; 1998 Dec; 8(4):273-8. PubMed ID: 9928916
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine.
de Jong TR; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
Psychopharmacology (Berl); 2005 May; 179(2):509-15. PubMed ID: 15719219
[TBL] [Abstract][Full Text] [Related]
14. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors fluvoxamine and paroxetine restore forced exercise-induced temperature dysregulation in ovariectomized mice.
Ikeda M; Egawa T; Yamauchi A; Sohda Y; Koga A; Tominaga K; Shuto H; Kataoka Y
Eur J Pharmacol; 2008 Jan; 579(1-3):439-44. PubMed ID: 18155696
[TBL] [Abstract][Full Text] [Related]
16. [Differential features of SSRIs].
Cervera S
Rev Med Univ Navarra; 1997; 41(4):245-57. PubMed ID: 10420965
[TBL] [Abstract][Full Text] [Related]
17. Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers.
Bell C; Wilson S; Rich A; Bailey J; Nutt D
Psychopharmacology (Berl); 2003 Mar; 166(2):102-10. PubMed ID: 12536263
[TBL] [Abstract][Full Text] [Related]
18. [Withdrawal symptoms in connection with the use of selective serotonin reuptake inhibitors (SSRI)].
Gram LF
Ugeskr Laeger; 1998 Dec; 160(50):7291-3. PubMed ID: 9859737
[No Abstract] [Full Text] [Related]
19. Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities.
Saletu B; Frey R; Krupka M; Anderer P; Grünberger J; See WR
Sleep; 1991 Oct; 14(5):439-47. PubMed ID: 1836894
[TBL] [Abstract][Full Text] [Related]
20. Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.
Saruwatari J; Yasui-Furukori N; Niioka T; Akamine Y; Takashima A; Kaneko S; Uno T
J Clin Psychopharmacol; 2012 Apr; 32(2):195-9. PubMed ID: 22367658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
